Chatham Lodging Trust (CLDT) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
27 Nov, 2025Business performance highlights
RevPAR growth of 2.8% in FY '24 and 0.2% YTD Q3 '25, outperforming industry and peers for three consecutive years.
Hotel EBITDA margin of 35.5% is the highest among lodging REITs.
Portfolio quality enhanced through capital recycling, with six hotels sold for $101 million and a new acquisition in Phoenix at a 9% cap rate.
Limited supply growth in core markets, with a weighted average of 0.5%.
Current share price and valuation offer meaningful upside potential.
Financial strength and capital management
Net debt reduced by $445 million since 3/31/20, reflecting a 48% decrease.
Net debt/LTM EBITDA stands at 1.2x, indicating low leverage and capacity for growth.
$313 million in liquidity as of 9/30/25, with extended debt maturities after a recent credit facility refinancing.
Enterprise value of $794 million and implied cap rate of 10% on LTM corporate NOI.
Share repurchases and acquisitions are accretive to FFO/share.
Portfolio and market positioning
Portfolio concentrated in high-quality, attractive markets such as Silicon Valley, Los Angeles, Greater New York, and Phoenix.
66% of LTM EBITDA generated by extended stay hotels, with Residence Inn as the largest brand.
Highest RevPAR among limited-service focused lodging REITs.
Largest concentration of extended stay rooms among lodging REITs at 59%.
High quality assets in top markets with significant upside as business travel recovers.
Latest events from Chatham Lodging Trust
- Industry-leading margins and RevPAR, strong balance sheet, and upside from tech market recovery.CLDT
Investor presentation2 Mar 2026 - Industry-leading margins, reduced leverage, and a return to profitability set the stage for 2026.CLDT
Q4 202527 Feb 2026 - Q2 RevPAR up 4%, Phoenix hotel acquired, and balance sheet strengthened despite higher costs.CLDT
Q2 20242 Feb 2026 - Q3 RevPAR growth, asset sales, and tech market strength support debt reduction and outperformance.CLDT
Q3 202416 Jan 2026 - Q4 RevPAR up 4%, margins expand, and leverage falls as tech markets drive growth.CLDT
Q4 202423 Dec 2025 - Proxy covers trustee elections, auditor ratification, executive pay, and equity plan amendment.CLDT
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, compensation, and plan amendment.CLDT
Proxy Filing2 Dec 2025 - Board urges approval of Equity Incentive Plan amendment to sustain aligned, cost-effective pay.CLDT
Proxy Filing2 Dec 2025 - Q2 2025 delivered resilient RevPAR, reduced leverage, and robust share repurchases.CLDT
Q2 202523 Nov 2025